Marie Lepetit

Marie Lepetit is a Scientist in Medicinal Chemistry at Redx Pharma since August 2020, focusing on R&D for small molecule kinase inhibitors, particularly in "Hit to Lead" and "Lead optimisation." Responsibilities include designing synthesis routes, purifying, and analyzing compounds. Previously, at Galapagos as an Intern, Marie synthesized and analyzed compounds for SAR development and improved synthetic routes. Earlier internships at the Institute of Biomolecules Max Mousseron involved synthesizing compounds for immunoconjugate development and labeling peptides for imaging. Educational background includes a Master of Science in Chemistry from the University of Montpellier and a Bachelor's degree in Life Sciences, among other degrees.